#1 Clinical Trials Search in Europe

Ivabradine

Ivabradine is a medication that has been the subject of several clinical trials exploring its potential benefits in various heart-related conditions. These trials have investigated the use of ivabradine in patients with heart failure, septic shock, coronary artery disease, and other cardiovascular issues. The studies aim to evaluate ivabradine’s effectiveness in controlling heart rate, improving heart function, and potentially reducing complications associated with these conditions.

Table of Contents

What is Ivabradine?

Ivabradine is a medication primarily used to treat certain heart conditions. It’s also known by the brand names Procoralan and Corlentor[1]. This drug is unique because it can slow down your heart rate without affecting your blood pressure or the heart’s ability to pump blood[2].

How Does Ivabradine Work?

Ivabradine works by selectively inhibiting what’s called the “funny current” (If) in your heart’s natural pacemaker, the sinoatrial node. This current helps control your heart’s rhythm. By slowing down this current, ivabradine can reduce your heart rate without negatively affecting other aspects of your heart’s function[3]. This is different from other heart rate-lowering medications like beta-blockers, which can also lower blood pressure and reduce the heart’s pumping strength.

Conditions Treated with Ivabradine

Ivabradine is used to treat several heart-related conditions:

  • Heart Failure: It’s used in patients with chronic heart failure, particularly when the heart is not pumping blood as effectively as it should (reduced ejection fraction)[4].
  • Angina: Ivabradine can help relieve chest pain (angina) in people with stable coronary artery disease[5].
  • Inappropriate Sinus Tachycardia: This is a condition where the heart beats too fast even at rest[6].

Researchers are also exploring its potential use in other conditions, such as:

  • Septic Shock: A life-threatening condition caused by severe infection[2].
  • Multiple Organ Dysfunction Syndrome (MODS): A condition where two or more organs fail to function properly[7].
  • Atrial Fibrillation: An irregular and often rapid heart rhythm[3].
  • Prevention of Heart Damage from Cancer Treatments: Specifically, from a type of chemotherapy drugs called anthracyclines[8].

Dosage and Administration

Ivabradine is typically taken as a tablet by mouth, usually twice a day. The dosage can range from 2.5 mg to 7.5 mg, depending on your specific condition and how you respond to the medication[4]. It’s important to take ivabradine as prescribed by your doctor and not to adjust the dose without consulting them first.

Potential Benefits of Ivabradine

The potential benefits of ivabradine include:

  • Reducing heart rate without lowering blood pressure[2]
  • Improving symptoms of heart failure and angina[5]
  • Potentially reducing the risk of hospitalization for heart failure[4]
  • Improving exercise tolerance in some patients[5]

Side Effects and Precautions

Like all medications, ivabradine can cause side effects. Common side effects may include:

  • Visual disturbances (such as seeing flashing lights)[2]
  • Bradycardia (excessively slow heart rate)[2]
  • Atrial fibrillation (a type of irregular heartbeat)[2]

It’s important to discuss any side effects with your doctor. They may need to adjust your dose or consider alternative treatments.

Ongoing Research and Future Potential

Researchers are continually studying ivabradine to understand its full potential. Some areas of ongoing research include:

  • Its use in treating septic shock and multiple organ dysfunction syndrome[2][7]
  • Its potential to prevent heart damage from certain cancer treatments[8]
  • Its effectiveness in controlling heart rate in patients with atrial fibrillation[3]
  • Its ability to improve blood flow in the small blood vessels of the heart after procedures to open blocked arteries[9]

These studies may lead to new uses for ivabradine in the future, potentially helping even more patients with various heart conditions.

Aspect Details
Primary Uses Heart rate control in various cardiovascular conditions
Conditions Studied Heart failure, septic shock, coronary artery disease, atrial fibrillation
Mechanism of Action Selective inhibition of If channels in the sinoatrial node
Dosage Range Typically 2.5 mg to 7.5 mg twice daily
Administration Oral tablets
Potential Benefits Improved heart rate control, better cardiac function, increased exercise tolerance
Common Side Effects Bradycardia, atrial fibrillation, visual disturbances (phosphenes)
Unique Features Lowers heart rate without affecting blood pressure or contractility

FAQ

  • What is ivabradine and how does it work? Ivabradine is a medication that selectively inhibits the 'funny' current (If) in the heart's sinoatrial node. It works by slowing down the heart rate without affecting blood pressure or heart contractility. This makes it useful in conditions where a lower heart rate is beneficial.
  • In which heart conditions has ivabradine been studied? Clinical trials have explored ivabradine's use in various heart conditions, including heart failure with reduced and normal ejection fraction, septic shock, coronary artery disease, atrial fibrillation, and multiple organ dysfunction syndrome.
  • What are some potential benefits of ivabradine observed in clinical trials? Some potential benefits observed in clinical trials include improved heart rate control, better cardiac function, increased exercise tolerance, and potentially reduced complications in certain heart conditions. However, results may vary depending on the specific condition and patient population studied.
  • Are there any side effects associated with ivabradine? While ivabradine is generally well-tolerated, some reported side effects in clinical trials include bradycardia (slow heart rate), atrial fibrillation, and visual disturbances such as phosphenes (seeing flashes of light). The occurrence and severity of side effects can vary among individuals.
  • How is ivabradine administered in clinical trials? In most clinical trials, ivabradine is administered orally in tablet form. The dosage typically ranges from 2.5 mg to 7.5 mg twice daily, depending on the specific study protocol and patient response. Some trials may adjust the dose based on heart rate and individual patient factors.

Ongoing Clinical Trials on Ivabradine

  • Comparison of ivabradine, atenolol, and metoprolol for heart rate control in patients with ischemic heart disease before cardiac CT examination

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study on Heart Health in Type 2 Diabetes Patients Using Semaglutide and Dapagliflozin Combination

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study on Ivabradine for Preventing Heart Injury in Patients with Atherosclerosis Undergoing Noncardiac Surgery

    Not recruiting

    1 1 1
    Investigated drugs:
    Poland

Glossary

  • Ejection Fraction: The percentage of blood that is pumped out of the heart's left ventricle with each contraction. It is used to measure how well the heart is pumping blood.
  • Septic Shock: A severe condition that occurs when an infection leads to dangerously low blood pressure and organ failure.
  • Tachycardia: An abnormally rapid heart rate, typically defined as more than 100 beats per minute in adults.
  • Cardiac Resynchronization Therapy (CRT): A treatment for heart failure that uses a special type of pacemaker to coordinate the contractions of the heart's ventricles.
  • Microcirculatory Dysfunction: Impaired blood flow in the smallest blood vessels of the body, which can affect organ function and overall health.
  • Percutaneous Coronary Intervention (PCI): A non-surgical procedure used to open blocked coronary arteries and restore blood flow to the heart.
  • Atrial Fibrillation: An irregular and often rapid heart rhythm that can lead to blood clots in the heart.
  • Anthracycline-induced Cardiotoxicity: Heart damage caused by a class of chemotherapy drugs called anthracyclines, used to treat various types of cancer.
  • Global Longitudinal Strain (GLS): A measure of the heart muscle's ability to contract and relax, used to detect early signs of heart dysfunction.
  • NYHA Class: The New York Heart Association (NYHA) Functional Classification, a system used to categorize the extent of heart failure based on symptoms and physical limitations.

References

  1. https://clinicaltrials.gov/study/NCT01373619
  2. https://clinicaltrials.eu/trial/study-on-ivabradine-for-heart-rate-control-and-survival-in-adults-with-septic-shock/
  3. https://clinicaltrials.gov/study/NCT03987204
  4. https://clinicaltrials.gov/study/NCT03456856
  5. https://clinicaltrials.gov/study/NCT03866395
  6. https://clinicaltrials.gov/study/NCT02166060
  7. https://clinicaltrials.gov/study/NCT01186783
  8. https://clinicaltrials.gov/study/NCT04030546
  9. https://clinicaltrials.gov/study/NCT02507050